title: [Bullous dermatosis at distant sites in patients treated with heparin].
abstract: Since Perrinaud in 2006 first described three patients with hemorrhagic bullae in relation to the use of heparins, numerous cases have been published. Currently, this entity has been established as a clearly defined pathology. We review all reported cases, diagnostic features and features that differentiate it from other skin manifestations caused by heparin having a worse prognosis and requiring a precise identification.
authors.affiliation: Servicio de Dermatología y Venereología, Hospital del Sureste, Arganda del Rey , Madrid, España. Electronic address: maria.castellanos.gonzalez@gmail.com.
authors.forename: María
authors.initials: M
authors.lastname: Castellanos-González
authors.affiliation: Servicio de Hematología y Hemoterapia, Hospital Ramón y Cajal, Madrid, España.
authors.forename: Diego
authors.initials: D
authors.lastname: Velasco-Rodríguez
authors.affiliation: Servicio de Medicina Interna, Hospital del Sureste, Arganda del Rey, Madrid, España.
authors.forename: Ana Belén
authors.initials: AB
authors.lastname: Mancebo Plaza
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy
chemical_list: D000925:Anticoagulants; D006493:Heparin
keywords: Ampollas; Bullae; Heparin; Heparina; Necrosis